236 related articles for article (PubMed ID: 15995056)
21. Guillain-Barré syndrome in elderly people.
Leung SS
J Am Geriatr Soc; 2008 Feb; 56(2):381-2. PubMed ID: 18251836
[No Abstract] [Full Text] [Related]
22. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
Mehndiratta MM; Chowdhury D; Goel V
J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
[No Abstract] [Full Text] [Related]
23. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Koichihara R; Hamano S; Yamashita S; Tanaka M
Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
[TBL] [Abstract][Full Text] [Related]
24. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras.
Koul R; Chacko A; Ahmed R; Varghese T; Javed H; Al-Lamki Z
J Child Neurol; 2003 Nov; 18(11):767-71. PubMed ID: 14696904
[TBL] [Abstract][Full Text] [Related]
25. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Nobile-Orazio E; Bersano A
Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
[No Abstract] [Full Text] [Related]
26. Respiratory distress.
Kannikeswaran N; Mahajan PV
Clin Pediatr (Phila); 2005 Apr; 44(3):275-8. PubMed ID: 15821856
[No Abstract] [Full Text] [Related]
27. The successful use of i.v. gammaglobulin for Guillain-Barré syndrome following gold therapy in an RA patient.
Tektonidou MG; Skopouli FN
Clin Exp Rheumatol; 2003; 21(3):404-5. PubMed ID: 12846068
[No Abstract] [Full Text] [Related]
28. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
[No Abstract] [Full Text] [Related]
29. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
[TBL] [Abstract][Full Text] [Related]
30. [Chronic subdural haematoma and Guillain-Barré syndrome].
Vega-Basulto S; Domínguez-Nápoles M; Infante J; Gutiérrez-Muñoz F; Debessa-Fernández R; Basulto-Barroso M
Rev Neurol; 2004 Dec 16-31; 39(12):1194-6. PubMed ID: 15625641
[No Abstract] [Full Text] [Related]
31. A rare case of Guillain-Barre syndrome with pregnancy.
Vijayaraghavan J; Vasudevan D; Sadique N; Rajeswari KS; Pondurangi M; Jayshree
J Indian Med Assoc; 2006 May; 104(5):269-70. PubMed ID: 17058576
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
33. The Guillain-Barré syndrome at two hospitals in Trinidad, West Indies: a review of 26 patients.
Esack A; Teelucksingh S
West Indian Med J; 2010 Oct; 59(5):514-7. PubMed ID: 21473398
[TBL] [Abstract][Full Text] [Related]
34. Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Susuki K; Yuki N
Lancet; 2004 Apr; 363(9416):1236-7; author reply 1237-8. PubMed ID: 15081664
[No Abstract] [Full Text] [Related]
35. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
36. Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Rossi G; Locatelli F
Lancet; 2004 Apr; 363(9416):1237; author reply 1237-8. PubMed ID: 15081665
[No Abstract] [Full Text] [Related]
37. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
Dalakas MC
Ann Neurol; 2002 Jun; 51(6):667-9. PubMed ID: 12112069
[No Abstract] [Full Text] [Related]
38. Intravenous immunoglobulin responsive gastroparesis in a patient with diabetes mellitus.
Xu S; Inchley F; Nye E; Tan CY; Renouf D
Intern Med J; 2019 Nov; 49(11):1455-1456. PubMed ID: 31713331
[No Abstract] [Full Text] [Related]
39. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
Ortiz-Corredor F; Peña-Preciado M
Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
[TBL] [Abstract][Full Text] [Related]
40. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
